Cantrell Drug Company today announced amendment of its U.S.Food and Drug Administration(FDA)registration to include the new 503B"compounding outsourcing facility"designation established under the recently passed Drug Quality and Security ...
Tags: Cantrell Drug, cancer, FDA
Omnicell,Inc.(OMCL)today announced that its Pandora®business analytics solutions are now available for customers in the Middle East markets.Pandora is a leading medication and supply automation analytics tool in United States hospitals ...
According to newly published results from a survey of pharmacy directors, drug shortages remain a serious problem for patient safety. Nearly half of the responding directors reported adverse events at their facilities due to drug shortages, ...
Tags: drug shortages, patient care, adverse effects, patient outcomes
Latest Cancer News Only High-Risk Women Need Breast Cancer Gene Test Acupuncture No Better Than 'Sham' Version 80 Percent of Cancer Docs Have Faced Drug Shortage Angelina Jolie's Story Didn't Boost Knowledge Rural Cancer Survivors May ...
Tags: Health, Medicine, Tongue Cancer
Four out of five doctors who treat cancer were unable to prescribe their medication of choice at least once during a six-month period because of a drug shortage, according to a new survey. The survey also found that more than 75 percent ...
The US Food and Drug Administration (FDA) has approved the third drug to be offered in the new BD Simplist line of ready-to-administer prefilled generic injectables. The third BD Simplist product to be introduced includes Ondansetron ...
Sagent Pharmaceuticals has announced the temporary importation of 8.4% Sodium Bicarbonate Injection, USP into the US market from Australia-based Phebra. The temporary arrangement is to address the present critical shortage of non-FDA ...
Tags: Sagent, Sodium Bicarbonate Injection, drug, drug shortage
ChiRhoClin has relaunched an orphan drug product,ChiRhoStim(Human Secretin for Injection)used to diagnose pancreatic cancer and pancreatic exocrine dysfunction. The company has received permission to market the current batch of ...
Tags: ChiRhoClin, Chirhostim Drug, orphan drug product, pancreatic cancer